Final nail in the coffin of Sanofi Pasteur MSD

US pharma giant Merck & Co (NYSE: MRK) is now managing its own vaccines portfolio across Europe.

This follows the disbanding of Sanofi Pasteur MSD, the European vaccines joint venture between French pharma major Sanofi (Euronext: SAN) subsidiary Sanofi Pasteur and Merck & Co, which is known as MSD outside of the USA and Canada.

Sanofi Pasteur MSD, owned on a 50/50 basis by the two companies, was created in 1994 to develop and commercialize vaccines originating from both companies' pipelines to improve and promote public health in 19 European countries.